FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Attorney Blasts CDRH for 8,000-day Petition Delays

Attorney and data scientist Bradley Thompson blasts CDRH for its lengthy delays of up to 8,000 days in answering an average of 13 citizen petitions a ...

latest-news-card-1
Federal Register

User Fee Courier Delivery Address Change

Federal Register notice: FDA provides notice that the courier address used for user fee payments has changed effective 10/6.

latest-news-card-1
Federal Register

BD Vacutainers EUA Revoked

Federal Register notice: FDA announces that it revoked the Emergency Use Authorization issued to Becton, Dickinson for the BD Vacutainer Plus Citrate ...

latest-news-card-1
Federal Register

Ultram Not Withdrawn Due to Safety/Efficacy

Federal Register notice: FDA determines that Janssen Pharmaceuticals Ultram (tramadol hydrochloride) tablets, 50 mg, was not withdrawn from sale for s...

Biologics

Moderna Phase 3 Trial for Flu/Covid Vaccine

Moderna says it will start a Phase 3 trial of its investigational mRNA-1083 combination flu/Covid vaccine later this year.

latest-news-card-1
Federal Register

Proposed Rule on Lab-developed Tests

Federal Register notice: FDA proposes to amend its regulations to make explicit that in vitro diagnostic products (IVDs) are devices under the Federal...

latest-news-card-1
Biologics

Signature Biologics Illegally Marketing Cord Product

FDA warns Irving, TX-based Signature Biologics that it is illegally marketing its human umbilical cord product that is manufactured with CGMP deviatio...

latest-news-card-1
Human Drugs

Repeat CGMP Deviations at Fresenius Unit

FDA warns Fresenius Kabi about CGMP deviations in its Fenwal International unit in Maricao, Puerto Rico.

latest-news-card-1
Human Drugs

KVK-Tech Recalls 1 Betaxolol Lot

KVK-Tech recalls one lot of betaxolol tablets as a precautionary measure after a single oxycodone HCl tablet was found on the packaging line during th...

latest-news-card-1
Federal Register

Oncology Panel to Discuss Accelerated Approvals

Federal Register notice: FDA announces an 11/16 Oncologic Drugs Advisory Committee meeting to hear an update on the agencys accelerated approval progr...